Related Experiment Videos
Calcium-channel blockers for combined systemic hypertension and myocardial ischemia
Insights
Calcium-channel blockers are effective for treating patients with both hypertension and coronary artery disease. These drugs improve heart function and blood flow, offering a valuable treatment option.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coexisting systemic hypertension and coronary artery disease present complex treatment challenges.
- Calcium-channel blockers are investigated for their potential role in managing these conditions.
Purpose of the Study:
- To evaluate the clinical usefulness of calcium-channel blockers in patients with hypertension and coronary artery disease.
- To explore the therapeutic effects of calcium-channel blockers on cardiovascular parameters.
Main Methods:
- Clinical investigation of calcium-channel blockers as monotherapy.
- Assessment of effects on heart rate, blood pressure, contractility, and coronary blood flow.
Main Results:
- Calcium-channel blockers demonstrate usefulness in chronic stable angina and mild-to-moderate hypertension.
- Therapeutic effects include improved oxygen consumption determinants, coronary vasodilation, and systemic vasodilation.
- Benefits extend to improved ventricular compliance, left ventricular hypertrophy regression, and cardioprotection.
Conclusions:
- Calcium-channel blockers are effective in managing patients with concomitant coronary artery disease and systemic hypertension.
- They offer advantages over beta-blockers in specific populations (elderly, black patients) and those with contraindications like bronchospasm.
Abstract:
Scientific rationale suggests a potentially important role for the calcium-channel blockers in the treatment of patients with coexisting systemic hypertension and coronary artery disease. Clinical investigation confirms the usefulness of these drugs as monotherapy in the treatment of patients with chronic stable angina and mild-to-moderate hypertension. There are several therapeutic effects of the calcium-channel blockers in coronary artery disease. Beneficial actions on the major determinants of oxygen consumption, i.e., heart rate, blood pressure, and contractility, are generally seen. The potent coronary vasodilating actions of these drugs allow for increased coronary blood flow and alleviation of coronary vasospasm. The effectiveness of the calcium-channel blockers in hypertension appears to be primarily due to their ability to induce systemic vasodilation. Improvements in ventricular compliance, regression of left ventricular hypertrophy, and cardioprotection appear to be additional beneficial effects of the drugs. Calcium-channel blockers compare favorably with beta-blockers; they appear to be more effective than some beta-blockers in the treatment of hypertension in the elderly and black population and can be given to patients with bronchospasm or peripheral vascular disease. Calcium-channel blockers are a welcome addition to existing drug regimens available for the management of patients with concomitant coronary artery disease and systemic hypertension.